M&A Deal Summary

Charles River Laboratories International Acquires Cerebricon Oy

On July 31, 2009, Charles River Laboratories International acquired life science company Cerebricon Oy

Acquisition Highlights
  • This is Charles River Laboratories International’s 5th transaction in the Life Science sector.
  • This is Charles River Laboratories International’s 1st transaction in Finland.

M&A Deal Summary

Date 2009-07-31
Target Cerebricon Oy
Sector Life Science
Buyer(s) Charles River Laboratories International
Deal Type Add-on Acquisition

Target

Cerebricon Oy

Kuopio, Finland
Cerebricon Oy, provides pharmaceutical discovery services foused on the central nervous system (CNS) diseases category.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Charles River Laboratories International

Wilmington, Massachusetts, United States

Category Company
Founded 1947
Sector Life Science
Employees18,700
Revenue 4.1B USD (2024)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.


DEAL STATS #
Overall 5 of 31
Sector: Life Science M&A 5 of 28
Type: Add-on Acquisition M&A Deals 4 of 26
Country: Finland M&A 1 of 1
Year: 2009 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-04-03 Piedmont Research Center

Morrisville, North Carolina, United States

Piedmont Research Center LLC is a provider of preclinical discovery services in oncology and other therapeutic areas.

Buy $46M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-08-01 Systems Pathology Co.

Seattle, Washington, United States

Systems Pathology Co. LLC is a pathology based software development company focused on developing analytical imaging technologies to automate the labor-intensive tissue evaluations process, which is a significant component of standard pre-clinical studies.

Buy -